Dialysis breakthrough? two simple Add-Ons may cut deadly complications

NCT ID NCT07335471

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two extra treatments for people on dialysis for kidney failure. One adds a special filter (hemoperfusion) to clean more toxins from the blood, aiming to reduce heart and brain complications. The other gives a steady sugar solution during dialysis to help patients who get dangerously low blood pressure. The trial involved 100 adults and checked if these methods improve safety and comfort during treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hemoperfusion and continuous high-glucose infusion
What this could lead to
If successful, these approaches could help dialysis patients have fewer heart and brain problems, and make dialysis sessions safer and more comfortable.
What could go wrong
This is a small, single-center study with only 100 participants, so results may not apply to everyone. Risks include bleeding, infection, and blood sugar changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES (CVD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Blood Purification Center, Suzhou Hospital Affiliated to Anhui Medical University

    Suzhou, Anhui, 234000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.